Amolifescience Co., Ltd.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Mar 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 8, 2027The maintenance fee for Dermal adhesive patch (US 11,717,657) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 1 fee due Mar 1, 2027The maintenance fee for Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide (US 9,119,816) comes due Mar 1, 2027. Unpaid by Sep 1, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Cosmetic pack and manufacturing method therefor (US 10,470,983) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,910,164 | Bifunctional magnetic core-semiconductor shell nanoparticles and manufacturing method thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,550,798 | Injection nozzle for electrospinning and electrospinning device using same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,647,090 | Injection nozzle for electrospinning and electrospinning device using the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,512,612 | Nano-fibered membrane for western blot and manufacturing method of the same In force · From the USPTO record | In force | From the USPTO record | |
| US 8,557,337 | Magnetic core—ceramic shell nanocrystals and manufacturing method thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,119,816 | Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide In force · From the USPTO record | In force | From the USPTO record | |
| US 9,457,063 | Method for treatment of diabetic vascular leakage-induced disease using C-peptide In force · From the USPTO record | In force | From the USPTO record | |
| US 10,859,570 | Methods for detecting an analyte using an analyte detection device In force · From the USPTO record | In force | From the USPTO record | |
| US 10,143,292 | Beauty sheet and method for manufacturing same In force · From the USPTO record | In force | From the USPTO record | |
| US 9,868,828 | Defined three-dimensional microenvironment for stem cell In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 37: 2 patents in force now held by others. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 2 abandoned · 11 no status recorded